Journal ArticleDOI
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
M. Grunnet,J.B. Sorensen +1 more
TLDR
The use of CEA as a prognostic and predictive marker in patients with lung cancer is widely debated and future studies may benefit from evaluating more than one marker at a time, to create a more precise index for prognosis and recurrence in lung cancer.About:
This article is published in Lung Cancer.The article was published on 2012-05-01. It has received 519 citations till now. The article focuses on the topics: Carcinoembryonic antigen & Tumor marker.read more
Citations
More filters
Journal ArticleDOI
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †
Silvia Novello,Fabrice Barlesi,Raffaele Califano,Raffaele Califano,Tanja Cufer,Simon Ekman,M. Giaj Levra,Keith M. Kerr,Sanjay Popat,Martin Reck,Suresh Senan,G Simo,Johan Vansteenkiste,Sanne Peters +13 more
TL;DR: The ESMO Guidelines Committee concluded that current state-of-the-art oncology practices in France, Belgium, and the Netherlands are suitable for frontline use and recommend further research into these practices.
Journal ArticleDOI
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
TL;DR: This paper discusses the role of peptides in cancer therapy with special emphasis on peptide drugs which are already approved and those in clinical trials, as well as highlighting the importance of combining immunotherapy with conventional therapies such as radiation and chemotherapy.
Journal ArticleDOI
Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".
David Planchard,Sanjay Popat,Keith M. Kerr,Silvia Novello,E.F. Smit,Corinne Faivre-Finn,Tony Mok,Martin Reck,P. Van Schil,Matthew D. Hellmann,Solange Peters +10 more
TL;DR: Department of Medical Oncology, Thoracic Group, Gustave-Roussy Villejuif, France; Royal Marsden Hospital, London; Aberdeen Royal Infirmary, Aberdeen University Medical School, Aberdeen, UK; Department of Oncologists, University of Turin, San Luigi Hospital, Orbassano, Italy.
Journal ArticleDOI
Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
Xinxin Zhu,Jinghe Lang +1 more
TL;DR: The objective of this systematic review was to elucidate the biological significance of soluble PD-1/PD-L1 in human cancers and evaluate whether they are potential diagnostic, therapeutic, or prognostic biomarkers.
Journal ArticleDOI
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
Y-L. Wu,David Planchard,S-N Lu,H Sun,Noboru Yamamoto,D-W. Kim,Daniel Shao-Weng Tan,J.C.-H. Yang,M Azrif,Tetsuya Mitsudomi,Kwang Bo Park,Ross A. Soo,J W C Chang,Adlinda Alip,Solange Peters,J.-Y. Douillard +15 more
TL;DR: These guidelines represent the consensus opinions reached by experts in the treatment of patients with metastatic NSCLC representing the oncological societies of China (CSCO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS) and were considered, during the final stages of the development of the Pan-Asian adapted Clinical Practice Guidelines.
References
More filters
Journal ArticleDOI
Estimates of the cancer incidence and mortality in Europe in 2006
TL;DR: The total number of new cases of cancer in Europe appears to have increased by 300,000 since 2004 and the ageing of the European population will cause these numbers to continue to increase even if age-specific rates remain constant.
Journal ArticleDOI
Estimates of cancer incidence and mortality in Europe in 2008.
TL;DR: The statistical models used used to estimate incidence and mortality data for 25 cancers in 40 European countries in 2008 used to obtain an estimate of the numbers of cancer cases and deaths in Europe in 2008.
Journal ArticleDOI
Carcinoembryonic Antigen, Squamous Cell Carcinoma Antigen, CYFRA 21-1, and Neuron-specific Enolase in Squamous Cell Lung Cancer Patients
TL;DR: CYFRA 21-1 is an independent prognostic factor in earlier stages and NSE in the advanced stages of SQC, and in multivariate analysis of survival, CYFRA21-1 was an independent but nonspecific prognosticfactor in the operable group of SQCs patients, whereas NSE was anindependent prognostic factors in theadvanced stages of disease.
Journal ArticleDOI
Cancer cells in transit: the vascular interactions of tumor cells.
TL;DR: This review presents the current mechanistic knowledge on vascular interactions of tumor cells, and it discusses biochemical and cell and molecular biology techniques used for the identification of novel receptor-ligand pairs mediating these interactions.
Journal ArticleDOI
Carcinoembryonic Antigen and CD44 Variant Isoforms Cooperate to Mediate Colon Carcinoma Cell Adhesion to E- and L-selectin in Shear Flow
TL;DR: The novel finding that CEA is an E- and L-selectin ligand may explain the enhanced metastatic potential associated with tumor cell CEA overexpression and the supportive role of selectins in metastasis.